Thrombopoietin Receptor Agonist [EPC]

Thrombopoietin Receptor Agonist [EPC] was reported 15182 times

Drugs of the Thrombopoietin Receptor Agonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 SPLENOSIS 8 0.4706
1 BONE MARROW RETICULIN FIBROSIS 117 0.4535
2 RETICULIN INCREASED 17 0.4474
3 BIOPSY BONE MARROW ABNORMAL 90 0.1982
4 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 89 0.1939
5 MUCOCUTANEOUS HAEMORRHAGE 28 0.1879
6 PLATELET COUNT ABNORMAL 962 0.1590
7 LEUKOERYTHROBLASTIC ANAEMIA 6 0.1304
8 SPLENECTOMY 138 0.1188
9 MEGAKARYOCYTES INCREASED 14 0.1129
10 BLOOD SMEAR TEST ABNORMAL 9 0.1125
11 EVANS SYNDROME 51 0.1034
12 THROMBOCYTOSIS 341 0.0930
13 LEUKOERYTHROBLASTOSIS 7 0.0700
14 ANTIBODY TEST 5 0.0685
15 MESENTERIC VASCULAR INSUFFICIENCY 7 0.0636
16 MEGAKARYOCYTES ABNORMAL 7 0.0619
17 MYELOPROLIFERATIVE DISORDER 14 0.0579
18 ANTI-PLATELET ANTIBODY POSITIVE 10 0.0578
19 CELLULITIS GANGRENOUS 11 0.0558
20 ACCESSORY SPLEEN 5 0.0556
21 MEGAKARYOCYTES DECREASED 5 0.0538
22 IDIOPATHIC THROMBOCYTOPENIC PURPURA 85 0.0538
23 MYELOFIBROSIS 158 0.0522
24 PLATELET MORPHOLOGY ABNORMAL 7 0.0511
25 IMMUNE THROMBOCYTOPENIA 225 0.0491
26 NEUTRALISING ANTIBODIES 6 0.0476
27 THROMBOCYTOPENIA NEONATAL 20 0.0475
28 NEUTRALISING ANTIBODIES POSITIVE 18 0.0432
29 MUCOSAL HAEMORRHAGE 44 0.0379
30 LYMPHADENITIS 91 0.0375
31 MARROW HYPERPLASIA 25 0.0367
32 PLATELET COUNT 20 0.0345
33 BONE MARROW MYELOGRAM ABNORMAL 6 0.0345
34 CHRONIC MYELOMONOCYTIC LEUKAEMIA 21 0.0318
35 PLATELET COUNT INCREASED 404 0.0310
36 ANGINA BULLOSA HAEMORRHAGICA 7 0.0302
37 ORAL BLOOD BLISTER 6 0.0300
38 EMBOLISM ARTERIAL 33 0.0275
39 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA 12 0.0256
40 BLAST CELLS PRESENT 12 0.0249
41 PETECHIAE 252 0.0241
42 CEREBRAL VENOUS SINUS THROMBOSIS 19 0.0225
43 IMMUNE THROMBOCYTOPENIC PURPURA 61 0.0216
44 ANTIPHOSPHOLIPID SYNDROME 34 0.0211
45 MONOCYTOSIS 13 0.0209
46 LARGE GRANULAR LYMPHOCYTOSIS 7 0.0208
47 PLATELET DISORDER 51 0.0202
48 NON-HODGKIN'S LYMPHOMA 24 0.0183
49 HAEMATOLOGICAL MALIGNANCY 51 0.0179
50 BONE MARROW DISORDER 54 0.0179
51 BASAL GANGLIA INFARCTION 6 0.0174
52 MYELODYSPLASTIC SYNDROME 246 0.0170
53 PLATELET COUNT DECREASED 1778 0.0167
54 CEREBRAL VENOUS THROMBOSIS 30 0.0165
55 CARDIAC VALVE VEGETATION 8 0.0165
56 ERYTHROMELALGIA 6 0.0164
57 BLAST CELL COUNT INCREASED 17 0.0162
58 CHRONIC LYMPHOCYTIC LEUKAEMIA 77 0.0162
59 HERPES SIMPLEX REACTIVATION 6 0.0157
60 THERAPEUTIC RESPONSE DECREASED 942 0.0155
61 HAEMOLYSIS 118 0.0153
62 HERPES SIMPLEX ENCEPHALITIS 7 0.0151
63 RENAL VEIN THROMBOSIS 10 0.0148
64 APLASTIC ANAEMIA 75 0.0143
65 MULTIMORBIDITY 17 0.0142
66 PROTEIN-LOSING GASTROENTEROPATHY 7 0.0141
67 ANTIPHOSPHOLIPID ANTIBODIES POSITIVE 8 0.0138
68 PORTAL VEIN THROMBOSIS 42 0.0130
69 INTERCEPTED PRODUCT ADMINISTRATION ERROR 99 0.0129
70 ECCHYMOSIS 87 0.0127
71 RED BLOOD CELL ABNORMALITY 12 0.0125
72 ANISOCYTOSIS 8 0.0122
73 MYELOPROLIFERATIVE NEOPLASM 8 0.0121
74 HAEMORRHAGIC DISORDER 13 0.0119
75 SPLENIC VEIN THROMBOSIS 6 0.0118
76 MYELODYSPLASTIC SYNDROME TRANSFORMATION 6 0.0115
77 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 8 0.0115
78 HAEMOPERITONEUM 9 0.0112
79 MOUTH HAEMORRHAGE 76 0.0104
80 MESENTERIC VEIN THROMBOSIS 10 0.0100
81 UPPER RESPIRATORY TRACT INFLAMMATION 12 0.0100
82 MIGRAINE WITH AURA 27 0.0099
83 PURPURA 87 0.0098
84 CEREBRAL ARTERY THROMBOSIS 5 0.0097
85 BLOOD BLISTER 30 0.0096
86 SUPERFICIAL VEIN THROMBOSIS 8 0.0095
87 THROMBOCYTOPENIA 1048 0.0094
88 INTRACRANIAL VENOUS SINUS THROMBOSIS 10 0.0093
89 PLATELET TRANSFUSION 12 0.0093
90 ARTERIAL THROMBOSIS 18 0.0093
91 ACUTE LEUKAEMIA 15 0.0093
92 BASOPHIL COUNT INCREASED 7 0.0092
93 INVESTIGATION 28 0.0089
94 ACUTE MYELOID LEUKAEMIA 135 0.0087
95 RETINAL VEIN THROMBOSIS 6 0.0086
96 THERAPEUTIC RESPONSE INCREASED 8 0.0085
97 BRAIN STEM HAEMORRHAGE 8 0.0085
98 ANAEMIA HAEMOLYTIC AUTOIMMUNE 7 0.0085
99 ANTIBODY TEST POSITIVE 14 0.0084
100 HAEMORRHAGIC DIATHESIS 30 0.0084
101 REFUSAL OF TREATMENT BY PATIENT 54 0.0083
102 SPLEEN DISORDER 14 0.0083
103 CAROTID ARTERY THROMBOSIS 7 0.0082
104 THROMBOTIC STROKE 6 0.0082
105 EMBOLISM 67 0.0081
106 GINGIVAL BLEEDING 106 0.0078
107 CEREBELLAR HAEMORRHAGE 11 0.0077
108 AUTOIMMUNE HAEMOLYTIC ANAEMIA 26 0.0076
109 IRON OVERLOAD 8 0.0074
110 VENOUS THROMBOSIS LIMB 15 0.0073
111 VIRAEMIA 10 0.0072
112 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 240 0.0071
113 SUBCLAVIAN VEIN THROMBOSIS 8 0.0070
114 ABDOMINAL LYMPHADENOPATHY 6 0.0069
115 BACTERIAL DISEASE CARRIER 5 0.0069
116 TRANSFUSION REACTION 6 0.0068
117 VENOUS THROMBOSIS 26 0.0066
118 VENA CAVA THROMBOSIS 11 0.0066
119 CONJUNCTIVAL HAEMORRHAGE 25 0.0065
120 PERIPHERAL ARTERY THROMBOSIS 9 0.0064
121 OVARIAN DISORDER 6 0.0064
122 THERAPY NON-RESPONDER 279 0.0062
123 DRUG EFFECT VARIABLE 7 0.0062
124 BRAIN HYPOXIA 6 0.0060
125 LOSS OF THERAPEUTIC RESPONSE 19 0.0060
126 DILATED CARDIOMYOPATHY 6 0.0059
127 SUDDEN HEARING LOSS 12 0.0059
128 B-CELL LYMPHOMA 20 0.0059
129 MULTIPLE MYELOMA 27 0.0058
130 SPLENIC INFARCTION 10 0.0057
131 THERAPEUTIC RESPONSE DELAYED 16 0.0057
132 NORMOCHROMIC NORMOCYTIC ANAEMIA 17 0.0057
133 SPLENOMEGALY 66 0.0056
134 CHRONIC MYELOID LEUKAEMIA 26 0.0056
135 JUGULAR VEIN THROMBOSIS 10 0.0056
136 COLON CANCER METASTATIC 9 0.0056
137 LYMPHOCYTOSIS 12 0.0056
138 HAEMOCHROMATOSIS 5 0.0054
139 HAEMORRHAGE INTRACRANIAL 80 0.0053
140 EMBOLISM VENOUS 16 0.0053
141 FIBROSIS 16 0.0052
142 THROMBOCYTOPENIC PURPURA 7 0.0051
143 DRUG SPECIFIC ANTIBODY 7 0.0051
144 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 14 0.0051
145 OCCUPATIONAL EXPOSURE TO PRODUCT 32 0.0050
146 LEUKOCYTOSIS 88 0.0049
147 DEEP VEIN THROMBOSIS 311 0.0048
148 HYPERCOAGULATION 9 0.0047
149 ANAEMIA MACROCYTIC 10 0.0047
150 GENE MUTATION 9 0.0045
151 CYTOGENETIC ABNORMALITY 5 0.0044
152 BLOOD LOSS ANAEMIA 10 0.0044
153 POLYCYTHAEMIA 9 0.0044
154 EMBOLIC STROKE 15 0.0043
155 ESCHERICHIA BACTERAEMIA 10 0.0042
156 BILE DUCT CANCER 5 0.0042
157 LUNG CANCER METASTATIC 12 0.0042
158 CARDIAC DEATH 5 0.0041
159 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 11 0.0041
160 LEUKAEMIA 39 0.0041
161 HAEMOLYTIC ANAEMIA 37 0.0041
162 GLIOBLASTOMA 7 0.0041
163 PULMONARY HAEMORRHAGE 32 0.0041
164 STEROID DIABETES 6 0.0040
165 INTERCEPTED PRODUCT PREPARATION ERROR 49 0.0040
166 THROMBOPHLEBITIS SUPERFICIAL 12 0.0040
167 PRODUCT PREPARATION ERROR 81 0.0039
168 PRODUCT STORAGE ERROR 345 0.0039
169 PERIPHERAL ISCHAEMIA 16 0.0039
170 LYMPHOMA 60 0.0039
171 ATRIAL THROMBOSIS 8 0.0039
172 EPISTAXIS 286 0.0038
173 NO THERAPEUTIC RESPONSE 46 0.0038
174 HAEMORRHAGE 391 0.0037
175 OROPHARYNGEAL BLISTERING 6 0.0037
176 PERICARDIAL HAEMORRHAGE 8 0.0037
177 INTRAVENTRICULAR HAEMORRHAGE 9 0.0036
178 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 8 0.0036
179 PORTAL HYPERTENSION 11 0.0036
180 PULMONARY ALVEOLAR HAEMORRHAGE 20 0.0036
181 LEUKAEMIA RECURRENT 6 0.0035
182 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 5 0.0035
183 LAZINESS 6 0.0035
184 APLASIA PURE RED CELL 12 0.0035
185 INTERCEPTED MEDICATION ERROR 16 0.0034
186 THERAPEUTIC PRODUCT EFFECT DECREASED 154 0.0034
187 CUSHINGOID 11 0.0034
188 HAEMOGLOBIN ABNORMAL 22 0.0034
189 RENAL FAILURE CHRONIC 26 0.0034
190 RED CELL DISTRIBUTION WIDTH INCREASED 14 0.0034
191 CYTOMEGALOVIRUS TEST POSITIVE 6 0.0034
192 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 7 0.0033
193 MANTLE CELL LYMPHOMA 5 0.0033
194 GRAFT VERSUS HOST DISEASE 23 0.0032
195 SYSTEMIC CANDIDA 8 0.0032
196 CEREBRAL THROMBOSIS 9 0.0032
197 CHEMOTHERAPY 12 0.0032
198 CYTOMEGALOVIRUS INFECTION REACTIVATION 14 0.0032
199 AORTIC STENOSIS 11 0.0032
200 PNEUMOCYSTIS JIROVECI PNEUMONIA 7 0.0031
201 HAEMATOMA 81 0.0031
202 CONTUSION 298 0.0031
203 VENTRICULAR DYSFUNCTION 8 0.0031
204 BACTERIAL SEPSIS 10 0.0031
205 APLASIA 6 0.0031
206 PULMONARY EMBOLISM 291 0.0031
207 BICYTOPENIA 6 0.0031
208 MELAENA 67 0.0030
209 HEPATIC CIRRHOSIS 57 0.0030
210 ISCHAEMIC STROKE 54 0.0030
211 ACUTE CORONARY SYNDROME 25 0.0030
212 HEAVY MENSTRUAL BLEEDING 27 0.0030
213 DEMENTIA ALZHEIMER'S TYPE 5 0.0030
214 WHITE BLOOD CELL COUNT INCREASED 114 0.0030
215 EAR HAEMORRHAGE 6 0.0030
216 INCREASED TENDENCY TO BRUISE 27 0.0029
217 PRODUCT LABEL CONFUSION 17 0.0029
218 URINARY BLADDER HAEMORRHAGE 6 0.0028
219 EYE CONTUSION 6 0.0028
220 NEUTROPHIL COUNT ABNORMAL 8 0.0028
221 CEREBRAL HAEMORRHAGE 101 0.0028
222 THERAPY PARTIAL RESPONDER 44 0.0028
223 ACUTE MYELOID LEUKAEMIA RECURRENT 6 0.0028
224 URINARY TRACT INFECTION BACTERIAL 7 0.0028
225 STAPHYLOCOCCAL BACTERAEMIA 12 0.0028
226 HYPOGAMMAGLOBULINAEMIA 18 0.0027
227 LYMPHOPROLIFERATIVE DISORDER 8 0.0027
228 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 11 0.0027
229 PAPILLOEDEMA 12 0.0027
230 SUBDURAL HAEMATOMA 38 0.0027
231 DRUG EFFECT DELAYED 12 0.0026
232 VARICES OESOPHAGEAL 8 0.0026
233 ACUTE MYOCARDIAL INFARCTION 78 0.0026
234 BONE MARROW TRANSPLANT 5 0.0026
235 LYMPHADENOPATHY MEDIASTINAL 5 0.0026
236 ISCHAEMIC CARDIOMYOPATHY 8 0.0026
237 REHABILITATION THERAPY 10 0.0026
238 SUBDURAL HAEMORRHAGE 7 0.0026
239 HOSPITALISATION 393 0.0026
240 CELL DEATH 5 0.0025
241 EMPYEMA 5 0.0025
242 SERUM SICKNESS 7 0.0025
243 FAILURE TO THRIVE 13 0.0025
244 CORONARY ARTERY THROMBOSIS 5 0.0025
245 PANCREATIC CARCINOMA METASTATIC 7 0.0025
246 IRON DEFICIENCY 11 0.0024
247 ACUTE RESPIRATORY DISTRESS SYNDROME 43 0.0024
248 ENTEROCOLITIS 14 0.0024
249 HAEMOTHORAX 7 0.0024
250 HAEMOGLOBIN INCREASED 11 0.0024
251 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 70 0.0024
252 IRON DEFICIENCY ANAEMIA 22 0.0024
253 BONE MARROW FAILURE 48 0.0024
254 HEPATIC NEOPLASM MALIGNANT 5 0.0024
255 SKIN HAEMORRHAGE 35 0.0024
256 HAEMORRHAGE URINARY TRACT 6 0.0024
257 SUBARACHNOID HAEMORRHAGE 24 0.0024
258 WHITE BLOOD CELL COUNT ABNORMAL 15 0.0023
259 PHLEBITIS 12 0.0023
260 MALNUTRITION 26 0.0023
261 HIV INFECTION 7 0.0023
262 POST PROCEDURAL HAEMORRHAGE 27 0.0023
263 DRUG SPECIFIC ANTIBODY PRESENT 15 0.0023
264 THROMBOPHLEBITIS 8 0.0023
265 THROMBOSIS 183 0.0023
266 THROMBOTIC THROMBOCYTOPENIC PURPURA 8 0.0023
267 HAEMORRHAGE SUBCUTANEOUS 8 0.0023
268 TERMINAL STATE 15 0.0022
269 HAEMATOCRIT INCREASED 5 0.0022
270 DRUG EFFECT DECREASED 118 0.0022
271 RED BLOOD CELL COUNT INCREASED 6 0.0022
272 HEPATITIS CHOLESTATIC 13 0.0022
273 IMMUNOSUPPRESSION 19 0.0022
274 LUNG NEOPLASM 9 0.0021
275 INTRA-ABDOMINAL HAEMORRHAGE 5 0.0021
276 PANCYTOPENIA 116 0.0021
277 ADENOVIRUS INFECTION 6 0.0021
278 HAEMATURIA 70 0.0020
279 GASTROINTESTINAL HAEMORRHAGE 170 0.0020
280 PNEUMONIA FUNGAL 8 0.0020
281 BACTERAEMIA 24 0.0020
282 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 15 0.0020
283 PRODUCT PREPARATION ISSUE 13 0.0020
284 RASH MACULO-PAPULAR 44 0.0020
285 ISCHAEMIA 9 0.0020
286 NEUTROPHIL COUNT INCREASED 20 0.0020
287 HEPATOSPLENOMEGALY 5 0.0019
288 MEAN CELL VOLUME INCREASED 5 0.0019
289 PRODUCT TEMPERATURE EXCURSION ISSUE 10 0.0019
290 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 5 0.0019
291 BRONCHOPULMONARY ASPERGILLOSIS 15 0.0019
292 NEUTROPHILIA 11 0.0019
293 SCLERODERMA 7 0.0019
294 INTERNAL HAEMORRHAGE 22 0.0019
295 SEPSIS 214 0.0019
296 DISSEMINATED INTRAVASCULAR COAGULATION 27 0.0019
297 CORONARY ARTERY BYPASS 11 0.0019
298 HEPATITIS C 23 0.0019
299 STRESS CARDIOMYOPATHY 11 0.0019
300 CLOSTRIDIUM DIFFICILE COLITIS 20 0.0019
301 RECTAL HAEMORRHAGE 81 0.0019
302 HYPOVOLAEMIC SHOCK 9 0.0019
303 PLEURAL EFFUSION 114 0.0019
304 ATELECTASIS 18 0.0019
305 METASTATIC NEOPLASM 8 0.0019
306 THROMBOTIC MICROANGIOPATHY 18 0.0018
307 HERPES SIMPLEX 12 0.0018
308 HEPATIC ENZYME INCREASED 125 0.0018
309 HOSPICE CARE 18 0.0018
310 HEPATIC ENCEPHALOPATHY 17 0.0018
311 BONE PAIN 106 0.0018
312 RHINOVIRUS INFECTION 7 0.0018
313 CYTOMEGALOVIRUS VIRAEMIA 8 0.0018
314 PROCEDURAL HAEMORRHAGE 7 0.0018
315 ENDOTRACHEAL INTUBATION 5 0.0018
316 MUSCULOSKELETAL PAIN 93 0.0018
317 CLOSTRIDIAL INFECTION 6 0.0018
318 ACUTE LYMPHOCYTIC LEUKAEMIA 5 0.0018
319 ACUTE GRAFT VERSUS HOST DISEASE 8 0.0017
320 ORGAN FAILURE 7 0.0017
321 CYSTITIS HAEMORRHAGIC 7 0.0017
322 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 95 0.0017
323 HYPERTRANSAMINASAEMIA 12 0.0017
324 ESCHERICHIA SEPSIS 5 0.0017
325 CAROTID ARTERY STENOSIS 6 0.0017
326 TRANSFUSION 18 0.0017
327 VIRAL INFECTION 57 0.0017
328 HYPOVOLAEMIA 10 0.0017
329 DRUG EFFECT INCOMPLETE 62 0.0017
330 ANGINA UNSTABLE 11 0.0017
331 RETINAL HAEMORRHAGE 12 0.0017
332 BRAIN HERNIATION 5 0.0017
333 HYPOALBUMINAEMIA 13 0.0017
334 BLOOD CULTURE POSITIVE 5 0.0017
335 RENAL TRANSPLANT 6 0.0017
336 TRANSIENT ISCHAEMIC ATTACK 56 0.0017
337 MONOCYTE COUNT INCREASED 6 0.0017
338 LIVER TRANSPLANT 6 0.0016
339 ABSCESS LIMB 7 0.0016
340 BLOOD ALBUMIN DECREASED 13 0.0016
341 HAEMORRHOIDAL HAEMORRHAGE 8 0.0016
342 VAGINAL HAEMORRHAGE 71 0.0016
343 MIGRAINE 156 0.0016
344 INTRACARDIAC THROMBUS 5 0.0016
345 HEPATOMEGALY 16 0.0016
346 OVARIAN CANCER 15 0.0016
347 UNEVALUABLE EVENT 123 0.0016
348 MULTIPLE ORGAN DYSFUNCTION SYNDROME 46 0.0016
349 WOUND HAEMORRHAGE 6 0.0016
350 LABORATORY TEST ABNORMAL 47 0.0016
351 NEUTROPENIA 214 0.0016
352 MULTI-ORGAN FAILURE 27 0.0016
353 PULMONARY THROMBOSIS 17 0.0016
354 HAEMOGLOBIN DECREASED 160 0.0016
355 CEREBRAL INFARCTION 38 0.0016
356 CEREBRAL ISCHAEMIA 8 0.0016
357 SUSPECTED OFF LABEL USE 7 0.0015
358 CANDIDA INFECTION 26 0.0015
359 PROSTATOMEGALY 6 0.0015
360 BLOOD LACTATE DEHYDROGENASE INCREASED 24 0.0015
361 EXPOSURE VIA BREAST MILK 6 0.0015
362 RED BLOOD CELL COUNT DECREASED 43 0.0015
363 MENINGITIS 10 0.0015
364 CANDIDIASIS 6 0.0015
365 ANAEMIA 283 0.0015
366 COLON CANCER 22 0.0015
367 PRE-ECLAMPSIA 7 0.0015
368 LUNG INFILTRATION 13 0.0015
369 HYDRONEPHROSIS 11 0.0015
370 GOITRE 6 0.0015
371 OFF LABEL USE 1282 0.0015
372 INFUSION RELATED REACTION 97 0.0015
373 ASCITES 43 0.0015
374 CAESAREAN SECTION 17 0.0015
375 INTESTINAL ISCHAEMIA 8 0.0015
376 IMMUNE SYSTEM DISORDER 19 0.0014
377 INTERMENSTRUAL BLEEDING 8 0.0014
378 SEPTIC SHOCK 62 0.0014
379 HAEMATOCRIT DECREASED 28 0.0014
380 UROSEPSIS 13 0.0014
381 HAEMORRHAGIC STROKE 11 0.0014
382 FIBRIN D DIMER INCREASED 5 0.0014
383 VEIN DISORDER 7 0.0014
384 CARDIAC OPERATION 12 0.0014
385 CHRONIC GRAFT VERSUS HOST DISEASE 5 0.0014
386 BLOOD DISORDER 11 0.0014
387 DIVERTICULUM INTESTINAL 6 0.0014
388 RESPIRATORY FAILURE 99 0.0014
389 BENIGN PROSTATIC HYPERPLASIA 7 0.0014
390 SHOCK HAEMORRHAGIC 11 0.0013
391 DECUBITUS ULCER 11 0.0013
392 DRUG INEFFECTIVE 1768 0.0013
393 PROTHROMBIN TIME PROLONGED 8 0.0013
394 SYSTEMIC LUPUS ERYTHEMATOSUS 47 0.0013
395 AUTOIMMUNE THYROIDITIS 5 0.0013
396 PREMATURE DELIVERY 21 0.0013
397 NEPHROTIC SYNDROME 9 0.0013
398 PNEUMONIA BACTERIAL 12 0.0013
399 CYTOPENIA 16 0.0013
400 ACUTE RESPIRATORY FAILURE 25 0.0013
401 ANAL ABSCESS 7 0.0013
402 NORMAL NEWBORN 7 0.0013
403 PERFORMANCE STATUS DECREASED 6 0.0013
404 NEUTROPENIC SEPSIS 9 0.0013
405 CEREBROVASCULAR ACCIDENT 212 0.0013
406 RENAL FAILURE ACUTE 53 0.0012
407 ACUTE PULMONARY OEDEMA 7 0.0012
408 MUSCLE HAEMORRHAGE 5 0.0012
409 ENTEROCOCCAL INFECTION 6 0.0012
410 HEMIPARESIS 21 0.0012
411 SUDDEN DEATH 13 0.0012
412 HYPERURICAEMIA 5 0.0012
413 TOOTH EXTRACTION 15 0.0012
414 CYTOMEGALOVIRUS INFECTION 20 0.0012
415 VASCULITIS 14 0.0012
416 EOSINOPHIL COUNT INCREASED 10 0.0012
417 TREATMENT FAILURE 99 0.0012
418 CORONARY ARTERY STENOSIS 6 0.0012
419 DEATH 1016 0.0012
420 SINUS HEADACHE 7 0.0012
421 ESCHERICHIA URINARY TRACT INFECTION 5 0.0012
422 ENDOCARDITIS 6 0.0012
423 OEDEMA PERIPHERAL 142 0.0012
424 TONSILLITIS 6 0.0011
425 HAEMORRHAGIC ANAEMIA 5 0.0011
426 DUODENAL ULCER 8 0.0011
427 ABDOMINAL ABSCESS 5 0.0011
428 GASTRIC HAEMORRHAGE 13 0.0011
429 MENORRHAGIA 22 0.0011
430 COMPRESSION FRACTURE 6 0.0011
431 CARDIOGENIC SHOCK 16 0.0011
432 COVID-19 PNEUMONIA 13 0.0011
433 DISEASE COMPLICATION 5 0.0011
434 INFECTION 158 0.0011
435 CHOLECYSTITIS 13 0.0011
436 METASTASES TO CENTRAL NERVOUS SYSTEM 14 0.0011
437 LOCALISED OEDEMA 5 0.0011
438 SURGERY 63 0.0011
439 MACULAR OEDEMA 6 0.0011
440 LACERATION 10 0.0011
441 PNEUMONIA 344 0.0011
442 ENCEPHALOPATHY 26 0.0011
443 MATERNAL EXPOSURE DURING PREGNANCY 94 0.0011
444 NEUROLOGICAL SYMPTOM 6 0.0010
445 PHARYNGITIS 13 0.0010
446 MYOCARDITIS 12 0.0010
447 CARDIAC FAILURE 84 0.0010
448 NEOPLASM 12 0.0010
449 SKIN ATROPHY 6 0.0010
450 HERPES VIRUS INFECTION 6 0.0010
451 MYALGIA 176 0.0010
452 TRANSAMINASES INCREASED 23 0.0010
453 GUILLAIN-BARRE SYNDROME 5 0.0010
454 VITAMIN D DEFICIENCY 10 0.0010
455 BREAST CANCER METASTATIC 11 0.0010
456 INCORRECT DOSAGE ADMINISTERED 5 0.0010
457 COAGULOPATHY 17 0.0010
458 CARDIOMYOPATHY 15 0.0010
459 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 6 0.0010
460 BLOOD IRON DECREASED 12 0.0010
461 DIABETIC NEUROPATHY 5 0.0010
462 RENAL CYST 8 0.0010
463 RASH ERYTHEMATOUS 48 0.0010
464 RESPIRATORY TRACT INFECTION 26 0.0010
465 GANGRENE 6 0.0010
466 HEPATIC FAILURE 30 0.0010
467 HERPES ZOSTER 57 0.0010
468 LYMPHOPENIA 14 0.0010
469 DIALYSIS 14 0.0010
470 INGUINAL HERNIA 6 0.0010
471 HEADACHE 616 0.0010
472 DIVERTICULITIS 27 0.0010
473 LUNG NEOPLASM MALIGNANT 40 0.0010
474 CACHEXIA 5 0.0010
475 PIGMENTATION DISORDER 6 0.0010
476 MALIGNANT MELANOMA 13 0.0010
477 QUALITY OF LIFE DECREASED 13 0.0010
478 AGRANULOCYTOSIS 18 0.0010
479 SPINAL COMPRESSION FRACTURE 8 0.0010
480 BACTERIAL INFECTION 18 0.0010
481 FEBRILE NEUTROPENIA 64 0.0010
482 NEOPLASM MALIGNANT 64 0.0010
483 INTENTIONAL PRODUCT MISUSE 83 0.0009
484 CARDIAC FAILURE CONGESTIVE 76 0.0009
485 DRUG EFFECT LESS THAN EXPECTED 14 0.0009
486 HEPATIC FUNCTION ABNORMAL 35 0.0009
487 LYMPHADENOPATHY 33 0.0009
488 DEMENTIA 26 0.0009
489 PREMATURE BABY 28 0.0009
490 BEHAVIOUR DISORDER 5 0.0009
491 HAEMORRHOIDS 18 0.0009
492 TROPONIN INCREASED 7 0.0009
493 KNEE OPERATION 9 0.0009
494 ATRIAL FIBRILLATION 89 0.0009
495 WALKING AID USER 6 0.0009
496 STAPHYLOCOCCAL INFECTION 30 0.0009
497 BLOOD PRESSURE ABNORMAL 18 0.0009
498 NECROSIS 5 0.0009
499 CYTOKINE RELEASE SYNDROME 18 0.0009
500 INTRACRANIAL PRESSURE INCREASED 5 0.0009
501 CARDIOMEGALY 11 0.0009
502 ANGIOPATHY 5 0.0009
503 UPPER GASTROINTESTINAL HAEMORRHAGE 15 0.0009
504 ARTERIAL OCCLUSIVE DISEASE 7 0.0009
505 ADVERSE EVENT 82 0.0009
506 GENERALISED OEDEMA 11 0.0009
507 POST PROCEDURAL COMPLICATION 17 0.0009
508 TRICUSPID VALVE INCOMPETENCE 7 0.0009
509 INFARCTION 6 0.0009
510 CELLULITIS 44 0.0009
511 HYPERBILIRUBINAEMIA 9 0.0009
512 STENT PLACEMENT 7 0.0009
513 BLOOD GLUCOSE ABNORMAL 16 0.0009
514 UPPER RESPIRATORY TRACT INFECTION 40 0.0009
515 NEUROPATHY PERIPHERAL 82 0.0009
516 METABOLIC DISORDER 5 0.0009
517 LIVER FUNCTION TEST ABNORMAL 25 0.0009
518 ARTHRALGIA 357 0.0009
519 DRUG RESISTANCE 22 0.0009
520 HYPOXIA 30 0.0009
521 BLOOD BILIRUBIN INCREASED 23 0.0009
522 OEDEMA 46 0.0008
523 THERAPEUTIC RESPONSE UNEXPECTED 38 0.0008
524 DIVERTICULUM 6 0.0008
525 DISEASE RECURRENCE 40 0.0008
526 PNEUMONIA ASPIRATION 21 0.0008
527 LIVER DISORDER 37 0.0008
528 HEPATITIS B 5 0.0008
529 ADVERSE REACTION 11 0.0008
530 DISEASE PROGRESSION 98 0.0008
531 MENTAL STATUS CHANGES 23 0.0008
532 CORONARY ARTERY DISEASE 25 0.0008
533 FLUID OVERLOAD 12 0.0008
534 EYE HAEMORRHAGE 11 0.0008
535 CARDIAC ARREST 68 0.0008
536 GASTROENTERITIS 12 0.0008
537 FACIAL PARALYSIS 7 0.0008
538 UTERINE LEIOMYOMA 6 0.0008
539 AUTOIMMUNE DISORDER 8 0.0008
540 THERAPY CHANGE 8 0.0008
541 RENAL FAILURE 108 0.0008
542 MENISCUS INJURY 5 0.0008
543 LOWER GASTROINTESTINAL HAEMORRHAGE 6 0.0008
544 CHOLANGITIS 5 0.0008
545 TREATMENT NONCOMPLIANCE 44 0.0008
546 SKIN INFECTION 9 0.0008
547 EPSTEIN-BARR VIRUS INFECTION 5 0.0008
548 GASTRITIS 21 0.0008
549 EYE INFECTION 9 0.0008
550 HYPERGLYCAEMIA 29 0.0008
551 ABDOMINAL PAIN 185 0.0008
552 BRAIN OEDEMA 10 0.0008
553 MYOCARDIAL ISCHAEMIA 9 0.0008
554 HAEMOPTYSIS 22 0.0008
555 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 41 0.0008
556 NEUTROPHIL COUNT DECREASED 32 0.0008
557 PULMONARY FIBROSIS 15 0.0008
558 JAUNDICE 21 0.0008
559 ASTHENIA 293 0.0008
560 METASTASES TO LUNG 9 0.0008
561 PERICARDIAL EFFUSION 18 0.0008
562 CONSTIPATION 168 0.0008
563 DYSPNOEA EXERTIONAL 29 0.0008
564 PULMONARY HYPERTENSION 16 0.0008
565 ASPERGILLUS INFECTION 5 0.0008
566 CARDIAC FAILURE ACUTE 5 0.0007
567 FLANK PAIN 7 0.0007
568 LOCALISED INFECTION 18 0.0007
569 RHINITIS 6 0.0007
570 ARTERIOSCLEROSIS 7 0.0007
571 BRONCHIECTASIS 5 0.0007
572 MYOCARDIAL INFARCTION 129 0.0007
573 PULMONARY MASS 11 0.0007
574 POST PROCEDURAL INFECTION 6 0.0007
575 BLOOD URINE PRESENT 14 0.0007
576 ASPHYXIA 6 0.0007
577 SMALL INTESTINAL OBSTRUCTION 9 0.0007
578 METASTASES TO BONE 12 0.0007
579 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 52 0.0007
580 PAIN IN EXTREMITY 214 0.0007
581 CYST 9 0.0007
582 GOUT 13 0.0007
583 ILEUS 9 0.0007
584 DIZZINESS POSTURAL 7 0.0007
585 VENTRICULAR FIBRILLATION 8 0.0007
586 AUTOIMMUNE HEPATITIS 5 0.0007
587 HYPOMAGNESAEMIA 10 0.0007
588 DECREASED IMMUNE RESPONSIVENESS 7 0.0007
589 DIABETES MELLITUS 54 0.0007
590 REBOUND EFFECT 8 0.0007
591 LEUKOPENIA 35 0.0007
592 PNEUMOCYSTIS JIROVECII PNEUMONIA 7 0.0007
593 MYOPATHY 6 0.0007
594 CARDIO-RESPIRATORY ARREST 29 0.0007
595 PRODUCT PRESCRIBING ISSUE 15 0.0007
596 MUSCULAR WEAKNESS 78 0.0007
597 BODY TEMPERATURE INCREASED 14 0.0007
598 ADVERSE DRUG REACTION 61 0.0007
599 HYPOPHOSPHATAEMIA 5 0.0007
600 PARAESTHESIA 106 0.0007
601 HEPATOTOXICITY 15 0.0007
602 CHOLELITHIASIS 22 0.0007
603 HAEMATEMESIS 17 0.0007
604 HYPERLIPIDAEMIA 8 0.0007
605 POLYNEUROPATHY 8 0.0007
606 HYPERTENSION 141 0.0007
607 FULL BLOOD COUNT ABNORMAL 7 0.0007
608 PYREXIA 229 0.0007
609 BLOOD COUNT ABNORMAL 10 0.0007
610 ADRENAL INSUFFICIENCY 8 0.0007
611 AORTIC ANEURYSM 5 0.0007
612 GENERAL PHYSICAL HEALTH DETERIORATION 76 0.0007
613 RASH GENERALISED 17 0.0007
614 ACCIDENTAL EXPOSURE TO PRODUCT 67 0.0006
615 DEVICE RELATED INFECTION 10 0.0006
616 BLOOD TEST ABNORMAL 9 0.0006
617 INTERSTITIAL LUNG DISEASE 31 0.0006
618 OSTEONECROSIS 21 0.0006
619 PROTEINURIA 12 0.0006
620 LOW BIRTH WEIGHT BABY 5 0.0006
621 PANCREATITIS 33 0.0006
622 DYSPEPSIA 61 0.0006
623 HIATUS HERNIA 8 0.0006
624 FATIGUE 478 0.0006
625 SCAB 7 0.0006
626 URINARY TRACT INFECTION 104 0.0006
627 CARDIAC DISORDER 57 0.0006
628 ESCHERICHIA INFECTION 5 0.0006
629 RENAL IMPAIRMENT 51 0.0006
630 LIVER FUNCTION TEST INCREASED 13 0.0006
631 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 43 0.0006
632 INFLUENZA 67 0.0006
633 OVARIAN CYST 6 0.0006
634 FUNGAL INFECTION 20 0.0006
635 HYPERKALAEMIA 21 0.0006
636 EMPHYSEMA 6 0.0006
637 WHITE BLOOD CELL COUNT DECREASED 64 0.0006
638 TOOTH ABSCESS 6 0.0006
639 LIMB INJURY 16 0.0006
640 PALLOR 16 0.0006
641 MACULAR DEGENERATION 7 0.0006
642 ASPARTATE AMINOTRANSFERASE INCREASED 31 0.0006
643 INSOMNIA 155 0.0006
644 RASH PAPULAR 13 0.0006
645 RESPIRATORY DISTRESS 16 0.0006
646 LUNG INFECTION 9 0.0006
647 MUSCLE STRAIN 5 0.0006
648 HYSTERECTOMY 5 0.0006
649 PROCEDURAL PAIN 16 0.0006
650 TENDERNESS 6 0.0006
651 NEOPLASM PROGRESSION 20 0.0006
652 WEIGHT FLUCTUATION 6 0.0006
653 CARPAL TUNNEL SYNDROME 8 0.0006
654 EOSINOPHILIA 10 0.0006
655 GROIN PAIN 5 0.0006
656 METASTASES TO LIVER 10 0.0006
657 SPINAL OPERATION 7 0.0006
658 PNEUMOTHORAX 9 0.0006
659 DRUG ERUPTION 10 0.0006
660 BLOOD ALKALINE PHOSPHATASE INCREASED 14 0.0006
661 CHILLS 66 0.0006
662 HAEMATOCHEZIA 31 0.0006
663 ILL-DEFINED DISORDER 34 0.0006
664 BACK PAIN 129 0.0006
665 GASTROENTERITIS VIRAL 10 0.0006
666 BACK DISORDER 9 0.0006
667 TOOTHACHE 10 0.0006
668 BONE DISORDER 10 0.0005
669 ASPIRATION 6 0.0005
670 FULL BLOOD COUNT DECREASED 11 0.0005
671 PRODUCT PRESCRIBING ERROR 13 0.0005
672 THERAPY INTERRUPTED 39 0.0005
673 SKIN DISCOLOURATION 25 0.0005
674 HYPERTENSIVE CRISIS 6 0.0005
675 DRUG DOSE OMISSION 89 0.0005
676 MALAISE 236 0.0005
677 ALANINE AMINOTRANSFERASE INCREASED 33 0.0005
678 NASOPHARYNGITIS 99 0.0005
679 HEPATIC STEATOSIS 10 0.0005
680 DIARRHOEA HAEMORRHAGIC 5 0.0005
681 TOOTH INFECTION 7 0.0005
682 FOETAL EXPOSURE DURING PREGNANCY 43 0.0005
683 MOBILITY DECREASED 38 0.0005
684 HYPOAESTHESIA 79 0.0005
685 MUSCULOSKELETAL DISORDER 10 0.0005
686 CHOLECYSTECTOMY 6 0.0005
687 VERTIGO 32 0.0005
688 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 9 0.0005
689 HIP ARTHROPLASTY 8 0.0005
690 MOUTH ULCERATION 11 0.0005
691 ARTHRITIS 41 0.0005
692 ORAL HERPES 10 0.0005
693 ACUTE HEPATIC FAILURE 7 0.0005
694 SKIN CANCER 11 0.0005
695 RESPIRATORY ARREST 14 0.0005
696 CATARACT 30 0.0005
697 SCIATICA 8 0.0005
698 ABSCESS 8 0.0005
699 WOUND 14 0.0005
700 HYPOKALAEMIA 23 0.0005
701 HIP FRACTURE 16 0.0005
702 SKIN REACTION 7 0.0005
703 MUCOSAL INFLAMMATION 13 0.0005
704 TOOTH DISORDER 11 0.0005
705 DYSURIA 18 0.0005
706 LETHARGY 28 0.0005
707 RASH MACULAR 17 0.0005
708 CONJUNCTIVITIS 9 0.0005
709 MENTAL DISORDER 21 0.0005
710 INJECTION SITE HAEMATOMA 7 0.0005
711 ABDOMINAL DISTENSION 50 0.0005
712 FRACTURE 9 0.0005
713 DIZZINESS 235 0.0005
714 IMMUNODEFICIENCY 7 0.0005
715 DIARRHOEA 303 0.0005
716 SLEEP DISORDER 33 0.0005
717 PRURITUS GENERALISED 10 0.0005
718 FAECES DISCOLOURED 10 0.0005
719 GASTROINTESTINAL DISORDER 41 0.0005
720 COVID-19 80 0.0005
721 ACTIVITIES OF DAILY LIVING IMPAIRED 9 0.0005
722 ANGINA PECTORIS 13 0.0005
723 MUSCULOSKELETAL CHEST PAIN 7 0.0005
724 GAMMA-GLUTAMYLTRANSFERASE INCREASED 10 0.0005
725 PANCREATIC CARCINOMA 13 0.0004
726 SKIN DISORDER 15 0.0004
727 BASAL CELL CARCINOMA 7 0.0004
728 GALLBLADDER DISORDER 8 0.0004
729 INCORRECT ROUTE OF DRUG ADMINISTRATION 16 0.0004
730 INTESTINAL PERFORATION 5 0.0004
731 NAUSEA 351 0.0004
732 RASH PRURITIC 24 0.0004
733 OSTEOMYELITIS 8 0.0004
734 TACHYPNOEA 6 0.0004
735 PNEUMONITIS 12 0.0004
736 OBESITY 7 0.0004
737 HYPOTHYROIDISM 14 0.0004
738 OSTEOPOROSIS 18 0.0004
739 INFLUENZA LIKE ILLNESS 36 0.0004
740 CHEST PAIN 81 0.0004
741 PERIPHERAL COLDNESS 6 0.0004
742 FALL 145 0.0004
743 PERITONITIS 9 0.0004
744 NIGHT SWEATS 14 0.0004
745 ELECTROLYTE IMBALANCE 5 0.0004
746 HYPOPHAGIA 11 0.0004
747 DERMATITIS 9 0.0004
748 UNRESPONSIVE TO STIMULI 11 0.0004
749 VENTRICULAR TACHYCARDIA 7 0.0004
750 DIPLOPIA 11 0.0004
751 EATING DISORDER 9 0.0004
752 SINUS TACHYCARDIA 6 0.0004
753 CONVULSION 24 0.0004
754 PARALYSIS 6 0.0004
755 BRONCHITIS 31 0.0004
756 HYPERSOMNIA 12 0.0004
757 CHOLESTASIS 8 0.0004
758 MEDICATION ERROR 23 0.0004
759 HERNIA 8 0.0004
760 FLUID RETENTION 21 0.0004
761 C-REACTIVE PROTEIN INCREASED 15 0.0004
762 NECK PAIN 23 0.0004
763 FIBROMYALGIA 10 0.0004
764 NEURALGIA 10 0.0004
765 DISCOMFORT 25 0.0004
766 MUSCLE SPASMS 75 0.0004
767 WEIGHT DECREASED 114 0.0004
768 RENAL DISORDER 19 0.0004
769 INJECTION SITE EXTRAVASATION 5 0.0004
770 HYPERCALCAEMIA 5 0.0004
771 SINUS DISORDER 8 0.0004
772 PULMONARY OEDEMA 18 0.0004
773 LOCAL SWELLING 7 0.0004
774 ARRHYTHMIA 19 0.0004
775 PREGNANCY 8 0.0004
776 HYPOAESTHESIA ORAL 6 0.0004
777 DERMATITIS ALLERGIC 5 0.0004
778 RASH 173 0.0004
779 LYMPHOCYTE COUNT DECREASED 7 0.0004
780 HYPOTENSION 79 0.0004
781 DECREASED APPETITE 91 0.0004
782 RIB FRACTURE 8 0.0004
783 TENDONITIS 6 0.0004
784 BLOOD PRESSURE INCREASED 59 0.0004
785 RESTLESS LEGS SYNDROME 7 0.0004
786 BRAIN FOG 6 0.0004
787 DRUG-INDUCED LIVER INJURY 12 0.0004
788 DEAFNESS 10 0.0004
789 INCORRECT PRODUCT STORAGE 5 0.0004
790 BEDRIDDEN 5 0.0004
791 STOMATITIS 23 0.0004
792 FEELING HOT 23 0.0004
793 PROSTATE CANCER 30 0.0004
794 DRUG INTOLERANCE 36 0.0004
795 DYSARTHRIA 14 0.0004
796 CONFUSIONAL STATE 60 0.0004
797 SYNCOPE 37 0.0004
798 INFLAMMATION 19 0.0004
799 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
800 EYE DISORDER 12 0.0004
801 CORONARY ARTERY OCCLUSION 5 0.0004
802 SKIN LESION 10 0.0004
803 PHOTOSENSITIVITY REACTION 6 0.0004
804 DYSPNOEA 204 0.0004
805 EAR PAIN 7 0.0004
806 PLASMA CELL MYELOMA 14 0.0004
807 ORAL PAIN 8 0.0004
808 COUGH 100 0.0004
809 ACCIDENTAL OVERDOSE 13 0.0004
810 FEELING ABNORMAL 85 0.0004
811 ABDOMINAL PAIN UPPER 73 0.0004
812 DISORIENTATION 14 0.0004
813 BLOOD CREATININE INCREASED 23 0.0004
814 METRORRHAGIA 6 0.0004
815 HEPATITIS 9 0.0004
816 HYPOACUSIS 15 0.0003
817 TINNITUS 16 0.0003
818 CYSTITIS 11 0.0003
819 TASTE DISORDER 7 0.0003
820 INTENTIONAL PRODUCT USE ISSUE 30 0.0003
821 VOMITING 161 0.0003
822 ARTHROPATHY 19 0.0003
823 DIABETES MELLITUS INADEQUATE CONTROL 6 0.0003
824 SWELLING FACE 22 0.0003
825 TACHYCARDIA 30 0.0003
826 FLATULENCE 19 0.0003
827 WEIGHT INCREASED 75 0.0003
828 OROPHARYNGEAL PAIN 31 0.0003
829 MYELOSUPPRESSION 12 0.0003
830 PRESYNCOPE 8 0.0003
831 IMPAIRED WORK ABILITY 7 0.0003
832 PAIN 201 0.0003
833 POOR QUALITY SLEEP 7 0.0003
834 ABORTION SPONTANEOUS 13 0.0003
835 ABASIA 8 0.0003
836 FEELING COLD 9 0.0003
837 LIMB DISCOMFORT 10 0.0003
838 AMNESIA 21 0.0003
839 EXPOSURE DURING PREGNANCY 20 0.0003
840 BLINDNESS 13 0.0003
841 PHOTOPHOBIA 6 0.0003
842 CYANOSIS 5 0.0003
843 DELIRIUM 11 0.0003
844 HEAD INJURY 10 0.0003
845 ALOPECIA 62 0.0003
846 GASTRIC ULCER 6 0.0003
847 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
848 PRODUCTIVE COUGH 15 0.0003
849 ABDOMINAL DISCOMFORT 52 0.0003
850 MUSCLE TIGHTNESS 5 0.0003
851 GAIT DISTURBANCE 59 0.0003
852 CHOKING 6 0.0003
853 VISUAL IMPAIRMENT 38 0.0003
854 NASAL CONGESTION 18 0.0003
855 LUNG DISORDER 15 0.0003
856 IMPAIRED HEALING 10 0.0003
857 DISABILITY 6 0.0003
858 HYPONATRAEMIA 17 0.0003
859 SPINAL FRACTURE 6 0.0003
860 VISION BLURRED 41 0.0003
861 APHASIA 9 0.0003
862 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 60 0.0003
863 FEEDING DISORDER 6 0.0003
864 PRODUCT USE IN UNAPPROVED INDICATION 73 0.0003
865 ACUTE KIDNEY INJURY 45 0.0003
866 MENTAL IMPAIRMENT 7 0.0003
867 ERYTHEMA 59 0.0003
868 ROAD TRAFFIC ACCIDENT 12 0.0003
869 BURNING SENSATION 20 0.0003
870 SINUSITIS 29 0.0003
871 HEART RATE INCREASED 28 0.0003
872 PAIN IN JAW 8 0.0003
873 INTENTIONAL DOSE OMISSION 8 0.0003
874 URTICARIA 47 0.0003
875 RHINORRHOEA 18 0.0003
876 DEHYDRATION 37 0.0003
877 HYPERSENSITIVITY 51 0.0003
878 END STAGE RENAL DISEASE 5 0.0003
879 LOSS OF CONSCIOUSNESS 35 0.0003
880 BLISTER 15 0.0003
881 JOINT STIFFNESS 7 0.0003
882 FLUSHING 27 0.0003
883 COLITIS 10 0.0003
884 MALIGNANT NEOPLASM PROGRESSION 27 0.0003
885 EAR INFECTION 7 0.0003
886 FEELING JITTERY 5 0.0003
887 CONDITION AGGRAVATED 79 0.0003
888 GLAUCOMA 5 0.0003
889 INCORRECT DOSE ADMINISTERED 59 0.0003
890 NERVOUS SYSTEM DISORDER 8 0.0003
891 DYSGEUSIA 19 0.0003
892 PERIPHERAL SWELLING 39 0.0003
893 INJECTION SITE BRUISING 20 0.0003
894 METABOLIC ACIDOSIS 8 0.0002
895 JOINT SWELLING 30 0.0002
896 GASTROOESOPHAGEAL REFLUX DISEASE 20 0.0002
897 LIVER INJURY 6 0.0002
898 BALANCE DISORDER 21 0.0002
899 GAIT INABILITY 8 0.0002
900 HALLUCINATION 18 0.0002
901 INTESTINAL OBSTRUCTION 9 0.0002
902 KNEE ARTHROPLASTY 5 0.0002
903 CARDIOVASCULAR DISORDER 6 0.0002
904 BREAST CANCER 22 0.0002
905 OSTEOARTHRITIS 10 0.0002
906 COGNITIVE DISORDER 11 0.0002
907 JOINT INJURY 5 0.0002
908 RESPIRATORY DISORDER 7 0.0002
909 ERECTILE DYSFUNCTION 6 0.0002
910 OCULAR HYPERAEMIA 11 0.0002
911 ECZEMA 12 0.0002
912 DEPRESSION 52 0.0002
913 BRADYCARDIA 12 0.0002
914 TREMOR 37 0.0002
915 EXTRA DOSE ADMINISTERED 9 0.0002
916 FREQUENT BOWEL MOVEMENTS 6 0.0002
917 CHROMATURIA 5 0.0002
918 CRYING 8 0.0002
919 MOOD ALTERED 6 0.0002
920 ANXIETY 62 0.0002
921 POLLAKIURIA 9 0.0002
922 INJECTION SITE PAIN 65 0.0002
923 PRURITUS 81 0.0002
924 BLOOD PRESSURE DECREASED 14 0.0002
925 SPEECH DISORDER 11 0.0002
926 HYPERHIDROSIS 27 0.0002
927 TYPE 2 DIABETES MELLITUS 7 0.0002
928 MUSCULOSKELETAL STIFFNESS 18 0.0002
929 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
930 AGEUSIA 5 0.0002
931 NO ADVERSE EVENT 36 0.0002
932 ABDOMINAL PAIN LOWER 5 0.0002
933 GASTRIC CANCER 5 0.0002
934 OXYGEN SATURATION DECREASED 11 0.0002
935 DRUG ADMINISTRATION ERROR 6 0.0002
936 FEMUR FRACTURE 6 0.0002
937 SOMNOLENCE 39 0.0002
938 SWELLING 18 0.0002
939 NERVOUSNESS 10 0.0002
940 DYSPHAGIA 18 0.0002
941 DEPRESSED MOOD 10 0.0002
942 DRUG INTERACTION 30 0.0002
943 EYE SWELLING 7 0.0002
944 DYSPHONIA 11 0.0002
945 HYPOGLYCAEMIA 9 0.0002
946 ILLNESS 19 0.0002
947 MEMORY IMPAIRMENT 25 0.0002
948 ANAPHYLACTIC REACTION 10 0.0002
949 OVERDOSE 39 0.0002
950 URINARY RETENTION 6 0.0002
951 PALPITATIONS 21 0.0002
952 THROAT IRRITATION 8 0.0002
953 UNDERDOSE 13 0.0002
954 HOT FLUSH 13 0.0002
955 DYSSTASIA 5 0.0002
956 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
957 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 30 0.0002
958 IRRITABILITY 10 0.0002
959 BLOOD POTASSIUM DECREASED 5 0.0002
960 LACRIMATION INCREASED 5 0.0002
961 EPILEPSY 5 0.0002
962 ANGIOEDEMA 7 0.0002
963 SEIZURE 18 0.0002
964 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
965 NEPHROLITHIASIS 7 0.0002
966 DYSKINESIA 6 0.0001
967 CHEST DISCOMFORT 15 0.0001
968 BLOOD GLUCOSE DECREASED 7 0.0001
969 INJURY 10 0.0001
970 SKIN EXFOLIATION 12 0.0001
971 EYE PAIN 8 0.0001
972 ASTHMA 16 0.0001
973 DRY EYE 7 0.0001
974 THERAPY CESSATION 7 0.0001
975 PRODUCT DOSE OMISSION ISSUE 40 0.0001
976 BLOOD GLUCOSE INCREASED 25 0.0001
977 CHRONIC KIDNEY DISEASE 10 0.0001
978 AGITATION 9 0.0001
979 BLADDER CANCER 7 0.0001
980 ACNE 9 0.0001
981 WHEEZING 7 0.0001
982 DISTURBANCE IN ATTENTION 6 0.0001
983 BLOOD CHOLESTEROL INCREASED 5 0.0001
984 COMA 5 0.0001
985 DRY SKIN 13 0.0001
986 SKIN BURNING SENSATION 6 0.0001
987 TOXICITY TO VARIOUS AGENTS 14 0.0001
988 PRODUCT USE ISSUE 15 0.0001
989 INJECTION SITE REACTION 5 0.0001
990 COMPLETED SUICIDE 5 0.0001
991 PSORIASIS 7 0.0001